What was Beroni Group’s price range in the past 12 months?
Beroni Group lowest stock price was $0.01 and its highest was $0.82 in the past 12 months.
What is Beroni Group’s market cap?
Beroni Group’s market cap is $53.33M.
When is Beroni Group’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Beroni Group overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Beroni Group pay dividends?
Beroni Group does not currently pay dividends.
What is Beroni Group’s EPS estimate?
Beroni Group’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beroni Group have?
Beroni Group has 38,302,280 shares outstanding.
Which hedge fund is a major shareholder of Beroni Group?
Currently, no hedge funds are holding shares in BNIGF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Beroni Group
Beroni Group is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of FDA/CE approved virus diagnostic kits, an e-commerce platform for the sale of pharmaceutical products, and a development pipeline targeting oncology and cell therapies. The company has operations in Australia, the United States, China, and Japan.